A Study to Quantify Tumour Perfusion for Spine Metastasis Treated With Stereotactic Body Radiotherapy (SBRT)

Spine Metastasis Clinical Trial

Official title:
Reduction in Tumour Perfusion for Spine Metastasis Treated With Stereotactic Body Radiotherapy (SBRT)

Status Recruiting

Clinical Trial Summary

Pre-clinical evidence suggests that radiotherapy reduces tumour-associated vasculature. The investigators will conduct a single-arm prospective study to quantify the reduction in tumour vasculature post-radiotherapy

Clinical Trial Description

n/a

Study Design

Related Conditions & MeSH terms

Clinical Trial Details

NCT number	NCT03072979
Study type	Observational
Source	National University Hospital, Singapore
Contact	BALAMURUGAN VELLAYAPPAN, MBBS, FRANZCR
Phone	67795555
Email	bala_vellayappan@nuhs.edu.sg
Status	Recruiting
Phase	N/A
Start date	January 21, 2017
Completion date	December 31, 2018

View Details

See also
Status	Clinical Trial	Phase
Completed	`NCT01231061` - Spinal met_radiosurgery/SBRT Study	Phase 2
Completed	`NCT00928382` - A Pilot Study to Explore Serum and Imaging Biomarkers in Patients With Spinal Cord Compression	N/A
Terminated	`NCT02700308` - A Study of Kyphoplasty and Vertebroplasty in the Treatment of Spine Metastases	Phase 2
Recruiting	`NCT03853434` - Efficacy of Angiographic Embolization vs Non-embolization of Moderate/Poor Vascularized Vertebral Metastases on Intraoperative Bleeding During Surgery Decompression and Vertebral Stabilization.	N/A
Recruiting	`NCT02242786` - Diffusion-Weighted Magnetic Resonance Imaging	Phase 2